Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

Anesthesia; Adverse Effect Clinical Trial

— PI  

Official title:

Observational Study Relationship Between Perfusion Index Changes and Intraoperative Complications in Cardiovascular Autonom Neuropathia Type-2 DM Patients With Spinal Anesthesia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03869775
• Other study ID #: ErzincanU
• Status: Recruiting
• Start date: December 1, 2017
• Est. completion date: December 1, 2020

Study information

• Verified date: March 2019
• Source: Erzincan University
• Contact: FARUK SUBASI
• Phone: 5414247924
• Email: dr.faruksubasi[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Description:

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 240
• Est. completion date: December 1, 2020
• Est. primary completion date: December 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• the patient will be operated with spinal anesthesia

• over 18 years

• no additional disease and only DM

Exclusion Criteria:

• patients with additional disease

• patients under 18 years of age

• patients contraindicated in spinal anesthesia

Related Conditions & MeSH terms

• Anesthesia; Adverse Effect
• Intraoperative Complications

Intervention

Device:
• perfusion index monitor
perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor

Diagnostic Test:
• ewing test
ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardiovascular autonomous neuropathia diagnosis

Locations

Country	Name	City	State
Turkey	Erzincanu	Erzincan	Merkez

Sponsors (1)

Lead Sponsor	Collaborator
Erzincan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Perfusion index change	Perfusion index change in spinal anesthesia related cardiovascular autonom neuropatia	Day 1